Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001933
Filing Date
2024-11-13
Accepted
2024-11-13 16:01:55
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20240930x10q.htm   iXBRL 10-Q 1351754
2 EX-31.1 atxs-20240930xex31d1.htm EX-31.1 11120
3 EX-31.2 atxs-20240930xex31d2.htm EX-31.2 11133
4 EX-32.1 atxs-20240930xex32d1.htm EX-32.1 6673
  Complete submission text file 0001410578-24-001933.txt   5537898

Data Files

Seq Description Document Type Size
5 EX-101.SCH atxs-20240930.xsd EX-101.SCH 35118
6 EX-101.CAL atxs-20240930_cal.xml EX-101.CAL 40686
7 EX-101.DEF atxs-20240930_def.xml EX-101.DEF 153834
8 EX-101.LAB atxs-20240930_lab.xml EX-101.LAB 353716
9 EX-101.PRE atxs-20240930_pre.xml EX-101.PRE 244470
62 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20240930x10q_htm.xml XML 909876
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 241453880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)